Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group

The incidence and mortality of lung cancer have increased worldwide over the last decades, with an observed increased incidence particularly among elderly populations. It has not yet been determined whether erlotinib therapy exhibits the same efficacy and safety in elderly and younger patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: KURISHIMA, KOICHI, SATOH, HIROAKI, KABURAGI, TAKAYUKI, NISHIMURA, YOSHIHIRO, SHINOHARA, YOKO, INAGAKI, MASAHARU, ENDO, TAKEO, SAITO, TAKEFUMI, HAYASHIHARA, KENJI, HIZAWA, NOBUYUKI, NAKAMURA, HIROYUKI, NAWA, TAKESHI, KAGOHASHI, KATSUNORI, KISHI, KOJI, ISHIKAWA, HIROICHI, ICHIMURA, HIDEO, HASHIMOTO, TOSHIO, SATO, YUKIO, SAKAI, MITSUAKI, KAMIYAMA, KOICHI, MATSUMURA, TAKESHI, UNOURA, KOJI, FUKUOKA, TOSHIHIKO, UCHIUMI, KEIKO, NOMURA, AKIHIRO, FURUKAWA, KINYA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915644/
https://www.ncbi.nlm.nih.gov/pubmed/24649255
http://dx.doi.org/10.3892/mco.2013.154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915644/
https://www.ncbi.nlm.nih.gov/pubmed/24649255
http://dx.doi.org/10.3892/mco.2013.154

Ejemplares similares